4.61
3.15%
0.13
Schlusskurs vom Vortag:
$4.48
Offen:
$4.79
24-Stunden-Volumen:
89,820
Relative Volume:
0.23
Marktkapitalisierung:
$14.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.21M
KGV:
-2.7278
EPS:
-1.69
Netto-Cashflow:
$-16.86M
1W Leistung:
+9.50%
1M Leistung:
-6.08%
6M Leistung:
-53.61%
1J Leistung:
-94.18%
Cingulate Inc Stock (CING) Company Profile
Firmenname
Cingulate Inc
Sektor
Branche
Telefon
(913) 942-2300
Adresse
1901 W. 47TH PLACE, KANSAS CITY
Vergleichen Sie CING mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CING | 4.62 | 14.34M | 0 | -21.21M | -16.86M | -1.69 |
VRTX | 450.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.27 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.34 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Cingulate Inc Aktie (CING) Neueste Nachrichten
U.S. Stock market top gainers: Binah Capital Group gains +107.02%, Aligos Therapeutics surges by 42.84% in mid day trading - Business Upturn
Cingulate Inc. Announces Third Quarter Financial Results and Clinical Update - Defense World
Cingulate Inc (CING) Quarterly 10-Q Report - Quartz
CINGCingulate Inc. Latest Stock News & Market Updates - StockTitan
Cingulate reports Q3 net loss $3.2M vs. $5.98M last year - TipRanks
Cingulate Reports Third Quarter 2024 Financial - GlobeNewswire
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market - StockTitan
Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - The Manila Times
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - GlobeNewswire
Cingulate secures funding to extend operations into Q2 2025 By Investing.com - Investing.com South Africa
SEC Form 424B3 filed by Cingulate Inc. - Quantisnow
Cingulate secures funding to extend operations into Q2 2025 - Investing.com India
Cingulate Inc. CEO faces domestic battery charge - Investing.com India
Cingulate Inc. CEO faces domestic battery charge By Investing.com - Investing.com South Africa
KC-area public company CEO faces charges for aggravated domestic battery - The Business Journals
Cingulate files to sell 1.5M shares of common stock for holders - MSN
Will Ciena's New 1.6 Tb/s Coherent Pluggable Solution Drive Top Line? - Zacks Investment Research
Concentrix Corp (CNXC) Q3 2024: Everything You Need to Know Ahea - GuruFocus.com
Cettire shares skyrocket - Finance News Network
Cettire gets auditor’s tick of approval, adding $247m to valuation - The Australian Financial Review
Stock of the day: Cettire - IG
Ciena Stock Goes to Buy From Sell at Citi. Here’s Why. - Barron's
Why Ciena Stock Popped 5% on Monday - The Motley Fool
Double-Upgrade Pushes Ciena Stock Near Record Highs - Schaeffers Research
Citi upgrades Ciena, shares rise in pre-market trade By Investing.com - Investing.com Canada
9 Analysts Assess Ciena: What You Need To Know - Benzinga
Ciena Unveils 1.6 Tb/s Coherent Pluggable Solution for Hyperscale Cloud Providers' Capacity Surge - Marketscreener.com
Ciena's stock rises after Citi double upgrades to Buy (NYSE:CIEN) - Seeking Alpha
Citi sees growth potential for Ciena stock as inventory challenges ease - Investing.com Australia
Ciena Co. (NYSE:CIEN) Shares Sold by Thrivent Financial for Lutherans - Defense World
KC-area pharmaceutical company starts its last trial before seeking FDA approval - The Business Journals
CING’s Market Whiplash: -94.12% YTD Decline, 192.68% Rise in 30 Days - The InvestChronicle
Cingulate Inc (CING)’s stock decline to 5.40 per share - US Post News
Where are the Opportunities in (CING) - Stock Traders Daily
Cingulate Inc (CING) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Cingulate Inc: Executive Pay Restored, Funding Up, FDA Study Launched - TipRanks
Cingulate initiates final study for ADHD asset CTx-1301 - TipRanks
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301 - GlobeNewswire
Market Insights: Cingulate Inc (CING)’s Notable Gain of 19.45, Closing at 6.51 - The Dwinnex
Cingulate regains Nasdaq compliance with bid price - Investing.com
Cingulate Shares Are Trading By More Than 200% Friday: What You Need To Know - MSN
Stocks of Cingulate Inc (CING) are poised to climb above their peers - SETE News
September 04, 2024 09:00 AM, Eastern - Nasdaq
Was there any good news for Cingulate Inc (CING) stock in the last session? - US Post News
Cingulate Inc. expands at-the-market offering by $3.87 million - Investing.com
Financial Health Report: Cingulate Inc (CING)’s Ratios Tell a Tale - The Dwinnex
CING’s 2023 Market Dance: Down -91.41% – Time to Invest? - The InvestChronicle
What's Going On With Cingulate Shares Recently? - MSN
Take off with Cingulate Inc (CING): Get ready for trading - SETE News
Cingulate Inc. reports increased share count following capital-raising - Investing.com
Cingulate Inc. reports increased share count following capital-raising By Investing.com - Investing.com UK
Finanzdaten der Cingulate Inc-Aktie (CING)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):